has been cited by the following article(s):
|
[1]
|
Ketamine-induced behavioral perturbations, redox imbalances, and neurotransmitter deficits in mice: The preventive and reversal neuromodulatory potential of diosmin as an antipsychotic
Brain Disorders,
2025
DOI:10.1016/j.dscb.2025.100210
|
|
|
|
|
[2]
|
Inhibition of oxidative stress, neuroinflammatory cytokines, and protein expressions contributes to the antipsychotic effects of geraniol in mice with ketamine-induced schizophrenia
Journal of Neuroimmune Pharmacology,
2025
DOI:10.1007/s11481-025-10226-1
|
|
|
|
|
[3]
|
Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission
IBRO Neuroscience Reports,
2024
DOI:10.1016/j.ibneur.2023.12.008
|
|
|
|
|
[4]
|
Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
Frontiers in Cellular Neuroscience,
2023
DOI:10.3389/fncel.2023.1139357
|
|
|
|
|
[5]
|
Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways
Brain Research Bulletin,
2018
DOI:10.1016/j.brainresbull.2018.02.007
|
|
|
|